Biotechnology News

August 6, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--UCSF and Fluidigm (NASDAQ:FLDM) scientists found shallow single-cell mRNA sequencing (approximately 50K reads per cell) is sufficient for unbiased classification of cell identities.

August 6, 2014

WITTEN, Germany--(BUSINESS WIRE)--SanguiBioTech is investigating new therapeutic approaches to treating septic shock and acute respiratory distress syndrome (ARDS) by applying hemoglobin based artificial oxygen carriers.

August 6, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO), today announced that it has entered into a technology and commercial license agreement with the University of Tennessee Research Foundation (UTRF) for the development of an...

August 6, 2014

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ: OFIX) today announced that it is delaying the release of its financial results for the fiscal quarter ended June 30, 2014. The Company requires additional time to evaluate...

August 6, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals Issues Voluntary U.S. Recall of Certain Lots of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials
Due to Presence of Particulate Matter

August 6, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against multidrug-resistant bacteria, today...

August 6, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScience to Present at the Wedbush Life Sciences Management Access Conference

August 6, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis to present at Wedbush 2014 Life Sciences Management Access Conference

August 6, 2014

JERUSALEM--(BUSINESS WIRE)--BioLineRx (NASDAQ: BLRX; TASE: BLRX) today reported its financial results for the second quarter ended June 30, 2014

August 6, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea reports second quarter 2014 financial results.

August 6, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Two in vivo studies evaluate motion patterns and kinematics in the knee for the first time using real-time mobile x-ray fluoroscopy

August 6, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, today announced the publication of...

August 6, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) collaborates with Imperial College London, providing funding for LeoPARDS Trial (Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis).

August 6, 2014

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) today announced the immediate availability in the U.S. of Nexxus Mobile Sales—the first complete cloud-based sales performance solution for life sciences. Nexxus Mobile Sales helps companies...

August 6, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nodality, Inc., an innovative biotechnology company advancing discovery, development and use of transformative therapies across broad therapeutic categories, with a focus on immunology and oncology,...

August 6, 2014

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company advancing NNR Therapeutics™, today reported its financial results for the second quarter and six months ended June 30, 2014....

August 6, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the second quarter of 2014, including revenue from sales of Iclusig® (ponatinib). The Company also provided an update on corporate...

August 6, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Insmed Incorporated (Nasdaq:INSM) today reported financial results for the three and six months ended June 30, 2014. Highlights of the second quarter of 2014 and recent weeks include: Announced plans to file a...

August 6, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea reported Q2 2014 financial results with revenue to Navidea from sales of Lymphoseek® growing to more than $1 million in Q2/2014 and reiterated revenue expectation of $5-6M for full-year 2014.

August 6, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. Reports 2nd Quarter 2014 Financial Results
Oncology arm of Pipeline Program expanded to include three different approaches for antibody-based cancer therapy

August 6, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Names Anne Whitaker Chief Executive Officer

August 6, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces that it will release its financial results for the three and six months ended June...

August 6, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical-stage pharmaceutical company and leader in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the initiation of the...

August 6, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on harnessing the potential of hypoxia-inducible factor (HIF) biology to develop and commercialize novel therapeutics to treat kidney...

August 6, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Reports Second Quarter Financial Results and Provides Corporate Update

August 6, 2014

NEW YORK--(BUSINESS WIRE)--Ophthotech Corporation (Nasdaq: OPHT) today provided an update on the Company’s business and announced financial results for the second quarter ended June 30, 2014.

August 6, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Appoints Dr. Holbrook Kohrt to Scientific Advisory Board

August 6, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended June 30, 2014, and also provided an overview of...

August 6, 2014

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals to Present at Canaccord Genuity Growth Conference

August 6, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals Inc. to Commence Series of Quarterly Conference Calls on Thursday, August 7, 2014. Call Scheduled for 4 PM Eastern Daylight Time

August 6, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Torax Medical today announced that the U.S. and European Patent Offices granted them patents on the use of Magnetic Gastric Band for the treatment of obesity. President and CEO of Torax Medical, Todd Berg, stated...

August 6, 2014

PINEBROOK, N.J.--(BUSINESS WIRE)--Alvogen acquires Korean Dream Pharma and creates a strong growth platform in the APAC region. Alvogen aims to create the first pan-regional generics pharmaceuticals company in the APAC region.

August 6, 2014

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Orexo AB (publ) (STO:ORX) announces today that Boehringer Ingelheim has decided to return the OX-MPI project to Orexo. The project aims to develop products based on specific inhibition of...

August 5, 2014

TRENTON, N.J.--(BUSINESS WIRE)--BioNJ announces that Thomas P. Richardson, Ph.D., MBA has been appointed to the newly created position of Vice President of Strategic Initiatives.

August 5, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ: ESPR) a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol)...

August 5, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that InVivo CEO Mark Perrin has been featured on The Wall Street Transcript (TWST), a service for investors and industry researchers that provides fresh...

August 5, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) announces that management will present at the Wedbush Life Science Conference on Wednesday, August 13, 2014 at 12.40 PM (EDT) at the Parker Meridian Hotel, New York, NY....

August 5, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori has placed enrollment in the ATHENA and ATHENA II trials on clinical hold and anticipates that it will not be possible to complete enrollment of the ATHENA I trial prior to the end of 2014.

August 5, 2014

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc., (NYSE MKT:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs,...

August 5, 2014

SEATTLE--(BUSINESS WIRE)--NanoString announced the Australian approval of the Prosigna Assay, which is the first diagnostic test for breast cancer approved by TGA for use in local, qualified clinical laboratories.

August 5, 2014

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central...

August 5, 2014

PARAMUS, N.J.--(BUSINESS WIRE)--Triple Threat's Tim Frank Named to PharmaVOICE 100

August 5, 2014

WASHINGTON--(BUSINESS WIRE)--BIO has opened registration for the 13th Annual BIO Investor Forum. The event will take place October 7-8, 2014, at the Palace Hotel in San Francisco, California.

August 5, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today issued its 2013 global corporate responsibility report, which focuses on the company’s corporate responsibility activities, progress and performance during 2013.

August 5, 2014

NORTHBROOK, Ill.--(BUSINESS WIRE)--Marathon Pharmaceuticals today announced the opening of the Marathon Bioscience Center in Chicago. The facility houses the company’s rare disease research, clinical and regulatory staff.

August 5, 2014

BRENTWOOD, Tenn.--(BUSINESS WIRE)--PathGroup and Cancer Clinics of Excellence (CCE) announce a newly formed partnership utilizing PathGroup’s versatile genomic profiling platform, SmartGenomics™.

August 5, 2014

ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO continues to expand its staffing and service offerings in North America in response to the increasing needs of its clients for global clinical trials.